Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
This is a Phase 1 trial evaluating SKLB1028 in subjects with relapsed or refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Sitagliptin Umbilical Cord Blood Transplant Study [Phase 2]
Phase 2 clinical trial update on sitagliptin in the setting of umbilical cord blood transplantation, with results posted in 2016 for several…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
A Phase II study evaluating clofarabine plus cytarabine in newly diagnosed acute myeloid leukemia was terminated, with results posted in Aug…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Optimal Treatment Strategy Based on for Pediatric AML [Phase 2]
Phase 2 clinical trial update evaluating optimal treatment strategies for pediatric acute myeloid leukemia, sponsored by Samsung Medical Cen…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia
A clinical trial update reports that transfusion dependence at diagnosis and higher transfusion intensity during initial chemotherapy are as…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia
A completed clinical study from Hospices Civils de Lyon investigating how patient age influences treatment decision-making in elderly indivi…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [Phase 2]
Phase 2 study evaluating unrelated cord blood transplantation using tacrolimus and sirolimus for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
A clinical trial update shows that a higher percentage of CD34+ CD38- cells in leukapheresis products, detected by multiparameter flow cytom…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen [Phase 2]
Phase 2 multi-center study evaluated a myeloablative allogeneic stem cell transplant using the CloBu4 regimen for non-remission acute myeloi…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 study of CEP-701 (lestaurtinib) in patients with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [Phase 2]
A Phase 2 trial testing nonmyeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors for multiple hematologic dis…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating the combination of gemtuzumab ozogamicin with high-dose cytarabine in relapsed or refractory acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2
Completed clinical trial studying whether natural killer cells' ability to kill leukemia cells correlates with outcomes in patients with acu…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia [Phase 3]
A Phase 3 clinical trial update examining HLA-mismatched microtransplantation for high-risk acute myeloid leukemia; the current status is UN…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Microtransplantation in Older Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating microtransplantation in older patients with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia [Phase 2]
Phase 2 study evaluating carboplatin plus topotecan in relapsed acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia
This clinical trial update reports results from a completed study comparing laboratory tests for minimal residual disease in patients with a…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase I trial evaluating a combination of midostaurin and bortezomib with chemotherapy in relapsed/refractory acute myeloid leukemia has c…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial comparing three regimens (high-dose lenalidomide; lenalidomide plus azacitidine; azacitidine) in adults ≥65 with newly diagnos…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
A completed diagnostic trial studied gene alterations in patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia [Phase 1, Phase 2]
A completed Phase 1/2 safety study evaluating CLT-008 (human myeloid progenitor cells) in patients with various leukemias after chemotherapy…
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission [Phase 2]
Phase 2 trial evaluating chemotherapy plus peripheral stem cell transplantation for acute myeloid leukemia in second remission has completed…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]
This Phase 2 trial update reports results of decitabine in adults with previously untreated acute myeloid leukemia, including patients acros…
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
A Stanford-sponsored clinical trial evaluating allogeneic transplantation for acute and chronic leukemias has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Allogeneic CART-33 for Relapsed/Refractory CD33+ AML [Phase 1]
Phase 1 clinical trial evaluating allogeneic CART-33 therapy for relapsed/refractory CD33-positive acute myeloid leukemia.